This is a StreetInsider.com Premium Only Page

Gilead Sciences (GILD) – StreetInsider.com Reports

Apr 17, 2024 08:14 AM Gilead Sciences (GILD) PT Lowered to $75 at UBS

Apr 15, 2024 04:48 PM Truist Securities Assumes Gilead Sciences (GILD) at Hold

Apr 9, 2024 09:40 AM Gilead Sciences (GILD) PT Lowered to $80 at Morgan Stanley

Apr 2, 2024 07:06 AM Nurix Therapeutics (NRIX) Announces Extension of Collaboration with Gilead Sciences (GILD)

Mar 28, 2024 08:31 AM FDA Expands Indication for Gilead's (GILD) Vemlidy to Treat Chronic HBV Infection in Pediatric Patients as Young as Six

Mar 28, 2024 07:05 AM Xilio Therapeutics (XLO) Announces $11.3 Million Private Placement Equity Financing, License Agreement with Gilead (GILD)

Mar 28, 2024 07:02 AM Gilead Sciences (GILD) and Xilio (XLO) Enter Exclusive License Agreement for Tumor-Activated IL-12 Program

Mar 22, 2024 09:56 AM Gilead (GILD) reduces 2024 earnings guidance after completing CymaBay takeover

Mar 22, 2024 09:18 AM Gilead Sciences (GILD) Announces Completion of Acquisition of CymaBay (CBAY)

Mar 15, 2024 10:25 AM BMO Capital Reiterates Outperform Rating on Gilead Sciences (GILD)

Mar 14, 2024 04:09 PM Gilead Sciences (GILD) Board Member Kevin Lofton to Retire

Mar 11, 2024 08:24 AM Gilead Sciences (GILD) Announces Expiration of Hart-Scott-Rodino Waiting Period for CymaBay (CBAY) Tender Offer

Mar 8, 2024 01:21 PM Oppenheimer remain bullish on Gilead Sciences (GILD), HIV agents in 24/25 could provide conviction to investors

Mar 6, 2024 10:25 AM Gilead Sciences (GILD) and Merck (MRK) Report Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24

Mar 6, 2024 08:01 AM Gilead Sciences (GILD), Merus (MRUS) Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers

Mar 5, 2024 04:35 PM Gilead Sciences (GILD) Reports New Real-World Data Supporting the Use of Veklury for People Hospitalized With COVID-19

Mar 5, 2024 04:31 PM Gilead Sciences (GILD) HIV Treatment Research Pipeline Aims to Address Unmet Needs and Advance Public Health

Mar 5, 2024 07:03 AM RedHill Biopharma's (RDHL) Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

Mar 4, 2024 04:54 AM Gilead Sciences (GILD) PT Lowered to $78 at Wells Fargo

Feb 26, 2024 04:07 PM Gilead Sciences (GILD) Announces FDA Approval of Expanded Indication for Biktarvy

Feb 26, 2024 08:33 AM Gilead Sciences (GILD) to Present Late-Breaking Data and Real-World Evidence Highlighting Innovative Antiviral Portfolio and Research Pipeline at CROI 2024

Feb 22, 2024 06:48 AM Gilead Sciences (GILD) PT Lowered to $90 at Mizuho Securities

Feb 22, 2024 06:04 AM Truist Securities Downgrades Gilead Sciences (GILD) to Hold

Feb 20, 2024 09:05 AM Gilead Sciences (GILD) and Biocytogen Enter Multi-Target Antibody Collaboration Agreement

Feb 14, 2024 05:24 AM Gilead Sciences (GILD) PT Lowered to $75 at RBC Capital

Feb 12, 2024 11:21 AM Midday movers: Diamondback Energy rises, Arm goes parabolic

Feb 12, 2024 08:55 AM Gilead Sciences (GILD) to acquire CymaBay Therapeutics (CBAY) in $4.3bn cash deal

Feb 12, 2024 08:42 AM Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment

Feb 12, 2024 08:32 AM Gilead Sciences (GILD) to Acquire CymaBay Therapeutics (CBAY) for $32.50 Per Share, $4.3 Billion

Feb 12, 2024 06:33 AM Gilead Sciences (GILD) PT Lowered to $105 at Oppenheimer, 'continue to be bullish on the name' despite weaker Q4 sales

Feb 12, 2024 03:00 AM Gilead Sciences (GILD) PT Lowered to $80 at Barclays

Feb 8, 2024 08:17 AM Gilead Sciences (GILD) PT Lowered to $83 at Morgan Stanley

Feb 8, 2024 05:54 AM Gilead Sciences (GILD) PT Raised to $81 at UBS

Feb 8, 2024 04:23 AM Gilead Sciences (GILD) PT Lowered to $80 at DZ Bank

Feb 7, 2024 09:01 AM Gilead Sciences (GILD) PT Lowered to $90 at TD Cowen

Feb 7, 2024 08:25 AM Gilead Sciences (GILD) PT Lowered to $95 at Piper Sandler

Feb 7, 2024 07:12 AM Gilead Sciences (GILD) PT Lowered to $84 at Wells Fargo

Feb 7, 2024 07:07 AM Gilead Sciences (GILD) PT Lowered to $76 at RBC Capital

Feb 7, 2024 05:57 AM Gilead Sciences Q4 earnings fall short of estimates

Feb 6, 2024 05:01 PM After-hours movers: Snap sinks, Ford surges, and more

Feb 6, 2024 04:07 PM Gilead Sciences (GILD) Declares $0.77 Quarterly Dividend; 4% Yield

Feb 6, 2024 04:06 PM Gilead quarterly revenue drops 4%, oral COVID drug fails trial

Feb 6, 2024 04:04 PM Gilead Sciences (GILD) Misses Q4 EPS by 4c; offers guidance

Feb 6, 2024 05:40 AM Eli Lilly earnings ahead, Toyota lifts annual guidance - what's moving markets

Feb 1, 2024 04:31 PM Gilead Sciences (GILD) Appoints Ted Love to its Board

Jan 30, 2024 08:31 AM Gilead Sciences (GILD) Reports Kite Granted FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta

Jan 29, 2024 05:04 PM After-hours movers: Supermicro, F5 Networks and more

Jan 29, 2024 05:01 PM Gilead Sciences (GILD), Arcus (RCUS) Announce Amended Collaboration and $320M Equity Investment

Jan 23, 2024 03:26 AM Gilead Sciences (GILD) PT Raised to $85 at Barclays

Jan 22, 2024 12:43 PM Gilead drops 11% after lung cancer drug trial fails, analyst says stock is 'overreacting'